A More Improved Lattice Action for Heavy Quarks

We extend the Fermilab formalism for heavy quarks to develop a more improved action. We give results of matching calculations of the improvement couplings at tree level. Finally, we estimate the discretization errors associated with the new action.Comment: 3 pages, 1 figure, Lattice 2003 Tsukuba Japa

Symmetry Breaking, Duality and Fine-Tuning in Hierarchical Spin Models

We discuss three questions related to the critical behavior of hierarchical spin models: 1) the hyperscaling relations in the broken symmetry phase; 2) the combined use of dual expansions to calculate the non-universal quantities; 3) the fine-tuning issue in approximately supersymmetric models.Comment: 3 pages, 1 figure, Lattice99 (spin

Universality, Scaling and Triviality in a Hierarchical Field Theory

Using polynomial truncations of the Fourier transform of the RG transformation of Dyson's hierarchical model, we show that it is possible to calculate very accurately the renormalized quantities in the symmetric phase. Numerical results regarding the corrections to the scaling laws, (i.e finite cut-off dependence) triviality, hyperscaling, universality and high-accuracy determinations of the critical exponents are discussed.Comment: LATTICE98(spin

Leptonic decay constants f_Ds and f_D in three flavor lattice QCD

We determine the leptonic decay constants in three flavor unquenched lattice QCD. We use O(a^2)-improved staggered light quarks and O(a)-improved charm quarks in the Fermilab heavy quark formalism. Our preliminary results, based upon an analysis at a single lattice spacing, are f_Ds = 263(+5-9)(+/-24) MeV and f_D = 225(+11-13)(+/-21) MeV. In each case, the first reported error is statistical while the is the combined systematic uncertainty.Comment: Talk presented at Lattice2004(heavy), Fermilab, June 21-26, 2004. 3 pages, 2 figure

Semileptonic D->pi/K and B->pi/D decays in 2+1 flavor lattice QCD

We present results for form factors of semileptonic decays of $D$ and $B$ mesons in 2+1 flavor lattice QCD using the MILC gauge configurations. With an improved staggered action for light quarks, we successfully reduce the systematic error from the chiral extrapolation. The results for $D$ decays are in agreement with experimental ones. The results for B decays are preliminary. Combining our results with experimental branching ratios, we then obtain the CKM matrix elements $|V_{cd}|$, $|V_{cs}|$, $|V_{cb}|$ and $|V_{ub}|$. We also check CKM unitarity, for the first time, using only lattice QCD as the theoretical input.Comment: Talk presented at Lattice2004(heavy); 3 pages, 3 figure

A limiting velocity for quarkonium propagation in a strongly coupled plasma via AdS/CFT

We study the dispersion relations of mesons in a particular hot strongly coupled supersymmetric gauge theory plasma. We find that at large momentum k the dispersion relations become omega = v_0 k + a + b/k + ..., where the limiting velocity v_0 is the same for mesons with any quantum numbers and depends only on the ratio of the temperature to the quark mass T/m_q. We compute a and b in terms of the meson quantum numbers and T/m_q. The limiting meson velocity v_0 becomes much smaller than the speed of light at temperatures below but close to T_diss, the temperature above which no meson bound states at rest in the plasma are found. From our result for v_0, we find that the temperature above which no meson bound states with velocity v exist is T_diss(v) \simeq (1-v^2)^(1/4) T_diss, up to few percent corrections.We thus confirm by direct calculation of meson dispersion relations a result inferred indirectly in previous work via analysis of the screening length between a static quark and antiquark in a moving plasma. Although we do not do our calculations in QCD, we argue that the qualitative features of the dispersion relation we compute, including in particular the relation between dissociation temperature and meson velocity, may apply to bottomonium and charmonium mesons propagating in the strongly coupled plasma of QCD. We discuss how our results can contribute to understanding quarkonium physics in heavy ion collisions.Comment: 57 pages, 12 figures; references adde

Immunocompromised patients with acute respiratory distress syndrome : Secondary analysis of the LUNG SAFE database

The aim of this study was to describe data on epidemiology, ventilatory management, and outcome of acute respiratory distress syndrome (ARDS) in immunocompromised patients. Methods: We performed a post hoc analysis on the cohort of immunocompromised patients enrolled in the Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure (LUNG SAFE) study. The LUNG SAFE study was an international, prospective study including hypoxemic patients in 459 ICUs from 50 countries across 5 continents. Results: Of 2813 patients with ARDS, 584 (20.8%) were immunocompromised, 38.9% of whom had an unspecified cause. Pneumonia, nonpulmonary sepsis, and noncardiogenic shock were their most common risk factors for ARDS. Hospital mortality was higher in immunocompromised than in immunocompetent patients (52.4% vs 36.2%; p < 0.0001), despite similar severity of ARDS. Decisions regarding limiting life-sustaining measures were significantly more frequent in immunocompromised patients (27.1% vs 18.6%; p < 0.0001). Use of noninvasive ventilation (NIV) as first-line treatment was higher in immunocompromised patients (20.9% vs 15.9%; p = 0.0048), and immunodeficiency remained independently associated with the use of NIV after adjustment for confounders. Forty-eight percent of the patients treated with NIV were intubated, and their mortality was not different from that of the patients invasively ventilated ab initio. Conclusions: Immunosuppression is frequent in patients with ARDS, and infections are the main risk factors for ARDS in these immunocompromised patients. Their management differs from that of immunocompetent patients, particularly the greater use of NIV as first-line ventilation strategy. Compared with immunocompetent subjects, they have higher mortality regardless of ARDS severity as well as a higher frequency of limitation of life-sustaining measures. Nonetheless, nearly half of these patients survive to hospital discharge. Trial registration: ClinicalTrials.gov, NCT02010073. Registered on 12 December 2013